Asian equities experienced their largest gain in two weeks, driven by Wall Street's rally and increased expectations for lower interest rates from the Federal Reserve. Technology stocks in Hong Kong surged by 2.7%, while Shanghai shares reached a decade high.
Circle Internet Group Inc.’s shares surged 20% after receiving a buy rating from Seaport Global, coinciding with new regulatory developments for cryptocurrencies. The company has seen a staggering 600% increase in shares since trading began.
In a surprising turn, stocks and the dollar soared after the US and China agreed to a 90-day tariff pause. This pivotal moment has investors optimistic, but is it enough to stabilize the markets long-term?
Stocks rose on Thursday following the announcement of a trade agreement between the U.S. and U.K., as investors eagerly await more details from President Trump amidst ongoing tariff negotiations.
The U.S. stock market has made a remarkable recovery following President Trump's unexpected tariffs. After a dramatic drop, the S&P 500 is back to its April levels, but uncertainty looms as companies adjust forecasts amidst turbulent trade policies.
President Trump's recent social media posts have ignited a market surge while raising concerns of potential insider trading. Lawmakers demand investigations into whether these actions were manipulative or merely reassuring.
Donald Trump's recent social media post claiming 'This is a great time to buy' sent stocks soaring after he announced a tariff pause, raising questions about market manipulation.
In a dramatic turn of events, President Trump's social media post urging followers to buy stocks coincided with a market surge following his tariff pause announcement. Democrats accuse him of market manipulation, igniting a fierce debate on ethics and insider trading.
The stock market experienced a significant boost today as President Trump announced a 90-day pause on reciprocal tariffs, leading to a surge in tech stocks, especially Nvidia, as optimism grows about AI and trade relations.
In a surprising turn, Indian drugmakers' shares jumped 5% following the U.S. exempting pharmaceuticals from new tariffs. This decision could significantly boost India's pharma exports, which reached $9 billion last year.
